TrialJournal of neuro-oncology2015

Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas.

Stéphane Goutagny et al.PubMed ↗Publisher ↗

No numbers read from the abstract.